Biopharma | May 05, 2026
Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025
The private funding rose 38% amid growing international collaborations and CDMO demand
The private funding rose 38% amid growing international collaborations and CDMO demand
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
The company has shown remarkable growth, posting a three-year CAGR of around 75% with an ARR of roughly Rs 100 crore and impressive gross margins
Sugemalimab, developed using CStone’s OmniRat transgenic platform, is a fully human IgG4 monoclonal antibody designed to minimize immunogenicity and toxicity
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
Subscribe To Our Newsletter & Stay Updated
